Reddit Posts
MBRX. Great opportunity ahead
💊 Moleculin Biotech (MBRX) — Small $50M Biotech With Big Potential Heading Into Year-End
IO Biotech (IOBT) and Moleculin Biotech (MBRX)
MBRX - if the stock doesn’t reach 1$ by the end of the year, they’ll get delisted
MBRX? I’ve read that if the stock doesn’t reach 1$ by the end of the year, they’ll get delisted. Do you think there’s still room for growth?
Insiders are betting big on biotech. Here’s why I’m watching closely.
Insiders buying up small-cap Biotech Stock ($BCAB, $SYRS, $PLSE, $ERAS, $LQDA, $CATX)
MBRX - Moleculin Presents Positive Preliminary Efficacy Findings from Phase 1B/2 Clinical Trial Demonstrating 64% Stable Disease Rate Through Two Cycles of Annamycin for the Treatment of Soft Tissue Sarcomas (STS) Lung Metastases
Moleculin Biotech $MBRX pipeline showing real promise while shorts pound away
MBRX broke out above the $1. 83 resistance. Still moving up with great cancer and covid pipeline!!!!
MBRX has great cancer and Covid treatments in their pipeline. Why does the FDA hold back great treatments for dying people???? Its been manipulated for to long. Its moving up nicely.
MBRX is about to get its fast track drug for cancer treatment soon!!!! It is on an slow uptrend. Looking like accumulating is occurring!!!
$MBRX Moleculin biotech $MBRX seems to have grit for sell
$MBRX Moleculin biotech $MBRX seems to have grit for sell
$MBRX Moleculin biotech $MBRX seems to have grit for sell
$MBRX Moleculin biotech $MBRX seems to have grit for sell
$Gme Brilliant Retail $MBRX Brilliant science !! BOTH GAME CHANGERS
$MBRX BRILLIANT SCIENCE $ GME BRILLIANT RETAIL CHANGED GAME STOP Bullish on both game changers !!
$MBRX 100% stop in-vitro covid replication to report in vivo results
Mentions
Chaikin Money Flow (CMF) for MBRX Spoiler: CMF for MBRX is off the chart. Better than very good, $MBRX is excellent. The Chaikin Money Flow (CMF) uses a standard period of 20 or 21 days. I’ll calculate the 20-day CMF using the most recent 20 trading days available as of January 6, 2026 (from Jan 5, 2026 back to Dec 2, 2025). Calculation Steps 1 Money Flow Multiplier (MFM) = [(Close - Low) - (High - Close)] / (High - Low) = (2 × Close - High - Low) / (High - Low) 2 Money Flow Volume (MFV) = MFM × Volume 3 20-day CMF = (Sum of MFV over 20 days) / (Sum of Volume over 20 days) Using recent daily data: Date High Low Close Volume MFM MFV Jan 5 3.8200 3.6400 3.7200 70,572 0.4444 31,365 Jan 2 3.6350 3.2500 3.6200 149,100 0.9610 143,306 Dec 31 3.3500 3.1700 3.3100 102,300 0.7778 79,567 Dec 30 3.4200 3.1300 3.3200 101,600 0.6552 66,569 Dec 29 3.8600 3.3200 3.4400 520,300 0.2222 115,622 Dec 26 3.9490 3.7800 3.8300 90,700 0.5917 53,654 Dec 24 4.1790 3.7800 3.9000 126,000 0.3015 38,000 Dec 23 4.2400 3.9200 4.1500 105,900 0.7188 76,125 Dec 22 4.1200 3.7400 4.0100 178,300 0.7105 126,692 Dec 19 4.0600 3.7500 3.9000 155,100 0.4839 75,035 Dec 18 4.1620 3.8100 3.8300 222,200 0.0568 12,623 Dec 17 4.3700 3.6300 4.1400 5,961,800 0.6892 4,109,000 Dec 16 4.7800 4.3600 4.6900 103,000 0.7857 80,929 Dec 15 5.0890 4.4200 4.5000 167,500 -0.1294 -21,683 Dec 12 5.2000 4.7500 4.9800 193,700 0.5111 99,000 Dec 11 5.3200 4.8900 5.0000 311,100 0.2558 79,570 Dec 10 5.8820 4.7500 4.8300 601,400 -0.9265 -557,200 Dec 9 7.5000 6.2000 6.6300 2,372,100 0.3308 784,800 Dec 8 7.9800 7.0100 7.2500 817,800 0.2474 202,400 Dec 2 6.8490 6.3300 6.6300 109,400 0.5769 63,115 Sum of MFV ≈ 6,438,489Sum of Volume ≈ 12,459,928 20-day CMF = 6,438,489 / 12,459,928 ≈ 0.517 Interpretation • A CMF value of +0.517 (strongly positive) indicates significant buying pressure and accumulation over the past 20 trading days. • This is unusually high for CMF (typically ranges -0.5 to +0.5), driven by high-volume spikes (e.g., Dec 17) where closes were in the upper part of the range. • Note: MBRX experienced volatility in December 2025, with a sharp drop mid-month followed by recovery, contributing to the strong positive flow recently.
MBRX jumping - Be aware!
MBRX climbing fast on low volume. Any ideas why?
MBRX great P1 news https://moleculin.com/moleculin-announces-positive-results-from-phase-1-clinical-trial-evaluating-wp1066-for-the-treatment-of-pediatric-recurrent-malignant-brain-tumors/
Anyone looking at MBRX or FBLG?
Got in $MBRX this morning, no movement on news whatsoever 😂
I have quite a lot of MBRX. Their main pipeline drug is annamycin. Has done very well in trials for relapsed/refractory AML. Phase 2B/3 trial is enrolling now. Predicting unblinding of data for the first 45 patients in Q1 2026. Based on prior trials and comments from CEO today about the blinded response data, I’m optimistic it will be good. Have a NASDAQ minimum price deadline on 12/24, but they may be able to get an extension. They do have authorization for reverse split and have used in the past so that’s a big risk. Definitely has potential to move a lot quickly on news. Happened recently, up 30% in a day on news about a conference.
Anyone in $MBRX ? Is it worthy to invest?
$MBRX https://www.stocktitan.net/news/MBRX/moleculin-reports-60-of-first-45-subjects-in-pivotal-miracle-phase-3-9fnqpwsh9cjp.html
Anyone know what's happening to MBRX?
Come on MBRX pump more
I'm not holding any at the moment. Currently in MBRX
I'm telling you man, MBRX is cookin' something
i personally haven't seen TNMG hyped anywhere and it surely is not as i said, institutions. this is dominant tv/net media with tech business and crypto holdings. I'm also eyeing RYVYL because they're lining up insanely to be a form of Neo Bank with Crypto and blockchain. They're partners and positioning is ridiculous. BUT they're also aligned more to larger investors and i wouldn't be surprised if they pulled a dilution at any stage before $1. So i'm weary but eyeing because, institutional. i just looked at MBRX and unless looking for short train gains in biotech i bought today RVPH: Validated Breakthrough in schizophrenia drugs and the drug can treat more than. success in trial phase 3, at most may have to do again but can skip if fda approves. schizophrenia is like wow, the world needs this. Especially with neuro machines/augmentation in humans being the future. Tech people wanting to reduce nuerological failures asap besides saving loved ones in old age. they present in two days to a ROTH meeting. and their price prediction is high asf. The 3 i've listed, i would expect to see over $1 within 12-36 months. catalysts can drive much sooner though i like to stay realistic. Hella yap and good luck to us all <3
Nah, I'm good. It's too hyped after today's pump. Doesn't feel organic. Best of luck to you, though! Check MBRX too, will be juicy as well
Love the look of MBRX. OPTT looking juicy too. TNMG is (though quite risky currently) appetizing also! Might jump in the latter mid-November though
I bought $MBRX - Moleculin Biotech Inc in July. About to buy more. I don't know why more people aren't.
I dont have any tickers rn, just didn't want to do this type of research just to have it go to waste cus the SEC decided what I was doing is illegal. The best I can do is say im up 221% YTD on webull and just dumped 77% of my portfolio in MBRX at 0.4042. (This is pure speculation and gambling at this point to be honest, which is a good deal of what im doing, I gambled when I grabbed 100 shares of Plug at 1.35 and the same with the 300 VYNE I got at 1.41.) However if I do any hobby research in the future, and find anything useful, I'll let the community know, with my findings so they can verify/ debunk my claims.
MBRX! Super Bullish, weekly chart looks like its about to go parabolic very soon
is anyone still watching MBRX?
I’m looking at MBRX. They have a Nasdaq compliance deadline coming up in December but also anticipate early results from data unblinding before end of year. They have an extension on the minimum bid issue after 12/24 possible and the 8-k write up sounds to me like maybe they will delay a reverse split as long as possible. Could make December spicy. Highly risky but maybe rewarding
So no for both because MBRX is a long way from approval and are already in a cash crunch, so most likely alot more dilution. IOBT has major cash issues as they will prob have to raise cash even before they submit the NDA (they say cash into 1Q 2026, approval at the earliest would be 4Q 2026), plus the trial narrowly missed its goal, which could cause issues with getting approval.
MBRX management so shady. Announced an exercise of warrants just after a day of releasing positive data.
Keep any eye on MBRX! Folks would catch up with the news sooner or later, [https://x.com/moleculinbio/status/1960704108022636614](https://x.com/moleculinbio/status/1960704108022636614)
$MBRX news [https://www.stocktitan.net/news/MBRX/moleculin-issues-new-positive-aml-overall-survival-kq02xgrxf478.html](https://www.stocktitan.net/news/MBRX/moleculin-issues-new-positive-aml-overall-survival-kq02xgrxf478.html)
Anyone have any thoughts on $MBRX stock?
MBRX # Analyst Sentiment & Price Targets * Several analysts exhibit strong optimism: * **TipRanks** reports a 12‑month average price target of **$7**, with a range of **$4 to $13** [Newser+15TipRanks+15StockInvest+15](https://www.tipranks.com/stocks/mbrx/forecast?utm_source=chatgpt.com). * **Fintel** shows a comparable forecast with an average target of **$7.14**, ranging from **$4.04 to $13.65** [Fintel](https://fintel.io/sfo/us/mbrx?utm_source=chatgpt.com). * **MarketBeat** cites a consensus target of **$4**, reflecting approximately **+515% upside** from the current level [MarketBeat](https://www.marketbeat.com/stocks/NASDAQ/MBRX/forecast/?utm_source=chatgpt.com). * [**Public.com**](http://Public.com) indicates a “Strong Buy” consensus, with a bullish price target as high as **$13.25** [Public+2TradingView+2](https://public.com/stocks/mbrx/forecast-price-target?utm_source=chatgpt.com).
MBRX # Analyst Sentiment & Price Targets * Several analysts exhibit strong optimism: * **TipRanks** reports a 12‑month average price target of **$7**, with a range of **$4 to $13** [Newser+15TipRanks+15StockInvest+15](https://www.tipranks.com/stocks/mbrx/forecast?utm_source=chatgpt.com). * **Fintel** shows a comparable forecast with an average target of **$7.14**, ranging from **$4.04 to $13.65** [Fintel](https://fintel.io/sfo/us/mbrx?utm_source=chatgpt.com). * **MarketBeat** cites a consensus target of **$4**, reflecting approximately **+515% upside** from the current level [MarketBeat](https://www.marketbeat.com/stocks/NASDAQ/MBRX/forecast/?utm_source=chatgpt.com). * [**Public.com**](http://Public.com) indicates a “Strong Buy” consensus, with a bullish price target as high as **$13.25** [Public+2TradingView+2](https://public.com/stocks/mbrx/forecast-price-target?utm_source=chatgpt.com).
MBRX with some news out
MBRX is a potential pump
Just a script in ChatGPT pretty much, just found MBRX, TLSA
My model also just spit something else that if you have powder left, you should look into, it’s called MBRX look into it model just spit that out Friday for me added to watchlist
MBRX holding strong. The recent news positive impact is in the making. [Moleculin Expands Phase 3 MIRACLE Clinical Trial into the Country of Georgia, Enrollment Update and Future Plans](https://finviz.com/news/99001/moleculin-expands-phase-3-miracle-clinical-trial-into-the-country-of-georgia-enrollment-update-and-future-plans)
MBRX! 
$MBRX is climbing get in before it's too late
I'm in VOR and CURR, watching MBRX NFA
Please don’t tell me you bought in MBRX ? 🤣
**GNPX** At 90D support level near 52w low as of today, may bounce tomorrow *but could continue down* **MBRX** Offering closed, should recover some tomorrow with the 1 year cash runway at current burn rate **MSAI** Nothing special here but looks like it might dip some further and rebound tomorrow. Decent company with high insider and institutional ownership. **WINT** Possible small recovery but likely will continue down **LCTX** Long on this one, looking like the FDA will ease up given the reduction in risk. It's been climbing.
**$MBRX**: June 23(after hours) CEO purchased 675k shares : https://www.ceo-buys.com/search?tickers=Mbrx+ Walter V. Klemp, the Company’s Chief Executive Officer, Jonathan P. Foster, the Company’s Chief Financial Officer, and certain other employees of the Company, purchased an aggregate of 1,027,026 Shares together with 3,081,078 Common Warrants in the Offering on the same terms as the other investors. - **Phase 3 MIRACLE Trial (AML)**: Dosing started Apr 2025; data due H2 2025 (Fast Track, Orphan Drug). - **Pediatric AML Study**: FDA-approved plan; high potential, high cost. - **STS Trial**: Positive Phase 1B/2 results (Jun 2025); AACR 2025 data upcoming. - **Patents**: U.S. protection to 2040. - **Funding/Regulatory**: $5.9M raised; EU trial expansion. Low cash **Risks**: Dilution June 23 public offering , trial failures, competition. FYI NFA.
Absolutely got torched by MBRX.
**Thursday, 6****^(th)** **March at 8:30 am** *New patents will extend coverage to major markets outside the U.S., expanding upon existing U.S. claims* *Affirms expectations for an initial data readout of the phase 3 MIRACLE trial for the second half of 2025* HOUSTON, March 6, 2025 /PRNewswire/ -- [**Moleculin Biotech, Inc.**](https://c212.net/c/link/?t=0&l=en&o=4376812-1&h=3904196879&u=https%3A%2F%2Fwww.moleculin.com%2F&a=Moleculin+Biotech%2C+Inc.), (NASDAQ: MBRX) (Moleculin or the Company), a late-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses, today announced it has received a Notice of Intent to Grant for the European patent application titled, "*Method of Reconstituting Liposomal Annamycin*". The grant is subject to payment of fees and completion of final amendments and formalities. Such grant will enhance the global exclusivity of Annamycin with the potential to be a next generation, non-cardiotoxic treatment for certain cancers.
PROP just [announced a $600M acquisition in the DJ Basin](https://finance.yahoo.com/news/prairie-operating-co-announces-acquisition-110000029.html) and immediately diluted shareholders with a $200M offering. Lmao classic oil and gas move. At least they're getting [25k barrels per day of new production](https://finance.yahoo.com/news/prairie-operating-co-announces-acquisition-110000029.html). Meanwhile MBRX doing what every penny biotech does - more offerings while burning cash. Tale as old as time.
MBRX still doing a lil.
Can't find any news on MBRX but it's moving..
https://preview.redd.it/phtw4qhym6le1.jpeg?width=1206&format=pjpg&auto=webp&s=d3bbcd40b8dbb6e87e7619be14b5e815b1a7f8f8 Anyone catches MBRX when the S1 withdrawal news out? I posted it in here
MBRX S1 withdrawal, https://www.sec.gov/Archives/edgar/data/1659617/000143774925004911/mbrx20250224_rw.htm
Does anyone know a sub where there is discussions over daily top gainers (only)? I normally read over top 10-20 daily gainers and the news behind it. Some stuff if more solid that other and may jump in when markets open. Just wondering if there are people doing the same thing? Like MLGO, MBRX… last week.
Recently made $4,500 on MBRX, put some of that into ADTX. Pennies go brrrrrrrt https://preview.redd.it/i70dicltl7ke1.jpeg?width=1229&format=pjpg&auto=webp&s=c393be66675692951e66b476f1f06591d1821e2e
100% this is why people can't make money sticking to stuff like " AUUD". I called ocea at .12 , SRM, MBRX, and CYCU and got downvoted all those times but look at how they performed. FYI, i place orders as soon as i let everyone know about the ticker
MBRX might be reaching a low at 1.5, if it find support here could move up once again??
100 or so shares of each, lets see how it works out. Ticker Avg 1-Day Gain (%) Volume Change (%) Sentiment Score 0 SRM 37.37 49714.50 0.85 1 MBRX 61.00 2072.84 0.30 2 SPGC 30.11 1743.21 0.62 3 ALLO 16.93 441.28 0.89
This is ur sign to get in KWE, this literally happened to MBRX
Mbrx is deffo on the radar. What’s thoughts on https://www.stocktitan.net/news/MBRX/moleculin-announces-exercise-of-warrants-for-5-8-million-gross-qjgnap80tsip.html
lol i did the same with OCEA at .12 and MBRX. didnt do a dd, just researched and called it. too lazy to type but happy for everyone who joined
MBRX may very well be the next DRUG 2.0. With a 9m dollar market cap , going into accelerated phase 3 with FDA positive guidance for their promising AML Leukemia treatment. people are starting to realize the potential significance of approving the first-ever non-cardiotoxic anthracycline. Up 183% last week , but at a 9m dollar market cap , pending FDA APPROVAL this has the pathway to go to 800m-1.5b market cap . $MBRX
Interesting picks! OSTX has some solid potential with that BLA submission. MBRX's big jump caught attention, could be a good one to track.
Is MBRX done running or is there expexted movement in after hours tdy?
Damn I got drunk and bought MBRX
Why haven’t i seen this sub push MBRX? Unless i missed it
I bet it will be halted like MBRX yesterday 
Yes, SRM is the next MBRX Great news and already taking of
guys. im in CNSP. but PLEASE! get back in on MBRX. it's shooting up! it might get back to where it was yesterday. even a 20% is a win!
MBRX and CNSP are the biggest changes in my port right now lol it's gonna be an amazing day once vol kicks in around 10 am et
MBRX didn’t finish so it’s going back up woot woot!
VRPX is the play, keep an eye on MBRX
$MBRX 
MBRX Is moving up, and although the stock price is up 70% the market cap for a late stage pharma is incredibly cheap
MBRX dip 
Got in MBRX. Unlike others it has real news backing
MBRX to hit 3 before open today
MBRX has low float and is a rocket ship. It has a phase 3 trial apporval
MBRX 
$SST still has 600K short shares available but a massive 12.74 days to cover. https://preview.redd.it/9bl61ef6t1je1.jpeg?width=1161&format=pjpg&auto=webp&s=5387d5d3574b9f3e8c49238c27a1913696fcfc2c Also $SSTS, $MGOL, $SPGC, $LHRC, $GNS, $CAPT, $DGLY. $OPTX has a 550% short sale borrowing rate. Missed $MBRX and $BSLK….
It happened with $MBRX and $BSLK today.
Redeemed myself with a nice win on MGOL today. Though I could have entered sooner. Had a few bucks leftover and gambled on MBRX and that bombed. Still holding though FDA phase 3 approvals are rare enough.